Billionaire Li Ka-Shing’s Drug Maker Hutchmed Sells $608 Million Stake In Cardiovascular Joint Venture 0 02.01.2025 07:45 Forbes.com Hutchmed, a biopharmaceutical company controlled by Hong Kong’s wealthiest person Li Ka-shing, is divesting a 45% stake in a cardiovascular joint venture for about $60... Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
